According to FutureWise analysis the market for anti-malarial drugs is expected to register a CAGR of 4.8% from 2023-2031.
Anti-malarial drugs are used for the treatment and prevention of malaria infection. These drugs primarily target the erythrocytic stage of malaria infection, which is responsible for the symptomatic illness. The effectiveness of pre-erythrocytic (hepatic) stage activity for most anti-malarial drugs is not well characterized. Treatment of the acute blood stage infection is crucial for malaria caused by all malaria species. Additionally, infections caused by Plasmodium ovale or Plasmodium vivax require terminal prophylaxis using a drug effective against hypnozoites. Hypnozoites are dormant forms of the parasite that can persist in the liver for months or even years after the initial infection.
By identifying the infecting Plasmodium species, healthcare providers can identify which infections will progress to severe symptoms and which will not. Additionally, some infections can remain dormant hypnozoites in the liver, leading to later relapses. A patient's clinical status is based on two main categories: uncomplicated malaria and severe malaria. The major difference in treatment is that uncomplicated malaria is treated with oral anti-malarials, while severe malaria gets treated with parenteral anti-malarials. Furthermore, healthcare professionals can select the most suitable treatment procedure by determining the drug susceptibility of the infecting Plasmodium species. This evaluation involves looking at where the patient was when they acquired the infection and whether they received any previous treatment with anti-malarials.
FutureWise Market Research has published a report that provides an insightful analysis of antimalarial drugs market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the anti-malarial drugs market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.